Skip navigation
More...

IV Leadership 

News and updates from today’s IV Leadership Summit hosted by 3M and chaired by Mark Easton, Home Editor, BBC. 

IV Therapy and Infection:  National Update and Developments
Annette Jeanes
, Director of Infection Prevention and Control & Infection Control Nurse Consultant, University College London Hospitals NHS Foundation Trust
Pre-Event Abstract: IV Therapy and Infection: National Update and Developments
There is a national ambition to reduce healthcare associated Gram-negative   bloodstream infections by 50% by 2021 and the initial focus will be on Escherichia coli bloodstream infections. There are competing infection control priorities including achieving zero MRSA bacteraemia, C.difficile reduction, surviving sepsis and reducing antibiotic resistance.

The role of leaders in IV therapy includes promoting on-going success in prevention of infection, continuing to improve practice and innovation.  The complexity of reducing gram negative infections is compounded by increasing levels of antibiotic resistant organisms. It is likely that in future the delivery of innovation and improvement associated with IV therapy will attract less resource as considerable improvement has already occurred.  The national targets are and opportunity to work with other specialists to identify potential areas for improvement, share solutions and promote best practice. 
Full PowerPoint Presentation

Primary complications and risks associated with vascular access: Current issues and challenges  
Jackie Nicholso
n, Global Committee Member World Congress on Vascular Access, Nurse Consultant Vascular Access, St George's University Hospitals NHS Foundation Trust
Pre-Event Abstract:
Complication rates associated with vascular access procedures have been estimated at between 1% and 26%. It is therefore important that all practitioners within this specialist field understand the risks and have the knowledge and tools to mitigate the risk. This presentation will give an overview of the commonly understood risks associated with vascular access procedures and identify ways in which these can be minimised. Case studies will be used to illustrate vascular access complications and give an understanding of the factors that may have contributed to the development of these difficulties.  
Full PowerPoint Presentation


Antimicrobial Resistance (AMR): How did we get here and what the future holds?
Shafi Mohammed, MPH CIC FRSPH, 
Director of Infection Prevention and Control, Cleveland Clinic Abu Dhabi
Pre-Event Abstract:
Globally, the damaging effects of antimicrobial resistance (AMR) are already manifesting themselves. It is estimated that AMR infections currently claim at least 50,000 lives each year across Europe and the US alone, with many hundreds of thousands more dying in other areas of the world. There is considerable variation globally in the trends of AMR, with different countries often experiencing different major challenges. Despite this and in contrast to some health issues, AMR is a problem that should concern every country irrespective of its level of income. The variation in the AMR problems of individual countries is linked to huge differences in how heavily they use antimicrobial drugs. It is estimated that the global consumption of antibiotics in human medicine rose by nearly 40% between 2000 and 2010, but this figure masks patterns of declining usage in some countries and rapid growth in others. Antimicrobial consumption has also increased in agriculture, aquaculture and livestock – all contributing to the development of AMR. Studies have shown that AMR cannot be stopped, but it can be slowed down with the use of appropriate evidence based interventions such as infection control, antimicrobial stewardship in healthcare, limit antimicrobial use in agriculture, aquaculture and livestock.
Full PowerPoint Presentation.

Resources:

www.3m.co.uk/tegadermchg Reducing Infection Risk At All Access Points. 3M Science has allowed for unique innovations that give you what you need to secure and protect every I.V. catheter—from insertion to removal

www.3m.co.uk/securement - Building on over 30 years of experience collaborating with clinicians to simplify and improve I.V. site care, 3M designed systems that provide reliable securement without sacrificing the comfort patients deserve

www.3m.co.uk/elearning - The 3M Health Care Academy is a training and educational resource for healthcare professionals who want to stay up-to-date in their professional life and progress their career

 

Future Events of Interest:

Gram-Negative Bloodstream Infection
Friday 16 November 
De Vere West One Conference Centre, London

Nurse Clinics 2018
Monday 19 November 
De Vere West One Conference Centre, London

IV Therapy Summit: Improving quality and safety including effective IV Therapy at home (OPAT)
Friday 23 November 
De Vere W1 Conference Centre, London

Developing the Role of the Physician Associate
Monday 26 November 
De Vere West One Conference Centre, London

National PROMs Summit 2018
Friday 7 December 
De Vere West One, London

Effective Clinical Director
Friday 7 December 
De Vere West One Conference Centre, London


9 October 2018

 PreviousNext 

    Partner Organisations

    The Tavistock and Portman NHS Foundation TrustInPracticeClinical Audit Support CentrePlayoutJust For Nurses
    GGI (Good Governance Institute) accredited conferences CPD Member ASGBI (Association of Surgeons of Great Britain and Ireland) professional partner BADS (British Association of Day Surgery) accredited conferences